Cheng, Yuan
Amgen (United States)
3 papers on CoChatORCID 0009-0000-7688-1295
Most cited papers
- Verified
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings
Véniant, M. M., Lu, S.-C., Atangan, L., Komorowski, R., Stanislaus, S., Cheng, Y., Wu, B., Falsey, J. R., Hager, T., Thomas, V. A., et al. (2024) · Nature Metabolism
Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity
Cited by 218
- Verified
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
Killion, E. A., Chen, M., Falsey, J. R., Sivits, G., Hager, T., Atangan, L., Helmering, J., Lee, J., Li, H., Wu, B., et al. (2020) · Nature Communications
Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases
Cited by 151
- Verified
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
Lu, S.-C., Chen, M., Atangan, L., Killion, E. A., Komorowski, R., Cheng, Y., Netirojjanakul, C., Falsey, J. R., Stolina, M., Dwyer, D., et al. (2021) · Cell Reports Medicine
Regulation of Appetite and ObesityDiabetes Treatment and Management
Cited by 91
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free